Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
Pedro Henrique Las Casas, Professor at Sorbonne University, Professor of Internal Medicine at Federal University of Minas Gerais (UFMG), Hematologist at Grupo Oncoclínicas, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cancers, adding:
“Happy to share our latest publication in Cancers with Grigoris Gerotziafas.
‘Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin‘
In this study, we explored how anticoagulant agents and quercetin influence cancer cell procoagulant activity, thrombin generation, and endothelial dysfunction induced by cancer-derived extracellular vesicles.
Our findings provide new insights into the complex interactions between cancer, thrombosis, and the vascular microenvironment.
I am grateful to my colleagues and collaborators for their valuable contributions, and especially proud to be part of the Cancer–Angiogenesis–Thrombosis and Hemostasis (CaVITE) research team at the CRSA PARIS, Inserm Paris UMR_S_938, Sorbonne Université.
Many thanks to all co-authors and collaborators who made this work possible.”
Title: Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin
Authors: Mohammed A. Baghdadi, Pedro Henrique Fernandes do Carmo Las Casas, Elisabeth Mbemba, Aurélie Rousseau, Prakasha Kempaiah, Andrey A. Svistunov, Victoria Bitsadze, Michèle Sabbah, Jawed Fareed, Patrick Van Dreden, Varvara Trachana, Eleftheria Lefkou, Grigoris Gerotziafas
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 10, 2026, 18:22Winai Porntipworawech: The $50 Life-Saving Drug Big Pharma Doesn’t Want You to See
-
Jun 10, 2026, 18:09Leonard Valentino: Innovation in Blood Disorders Being Catalyzed by Pathway to Cures
-
Jun 10, 2026, 18:00Smitirupa Mishra: Normal Hemoglobin Does Not Always Mean Normal Genes
-
Jun 10, 2026, 17:58Talat Uppal: Addressing HMB with RACGP’s Dr. Ramya Raman
-
Jun 10, 2026, 17:52Throw Back Thursday to Past Bruises Posted in the Glanzmann’s Research Foundation
-
Jun 10, 2026, 17:52Priya Prasad: In Massive Hemorrhage, Fibrinogen Is Often the First Clotting Factor to Fall
-
Jun 10, 2026, 17:51Mariam Swidan: Some Red Blood Cells Can’t Handle Pressure
-
Jun 10, 2026, 17:49Ankit Mathur: Hosting ISBT Academy Day on Rare Donor Program in India
-
Jun 10, 2026, 17:48Shadi Tabibian: When Patients Bleed but Standard Testing Is Normal